Evidence map›Paper›PMID 34211312›Full record

ArticleSubstance abuse and rehabilitation2021

Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures.

Diana E Clarke, Adila Ibrahim, Benjamin Doty, Sejal Patel, Debbie Gibson, Anna Pagano, Laura Thompson, Amy B Goldstein, Frank Vocci, Robert P Schwartz

Open access · goldAbstract read
In one paragraph

Article in Substance abuse and rehabilitation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Towards shortening the Brief Addiction Monitor-Revised (BAM-R).Drug and alcohol dependence reports · 2023
    Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Diana E ClarkeDivision of Research, American Psychiatric Association, Washington, DC, USA.
Adila IbrahimSocial Research Center, Friends Research Institute, Baltimore, MD, USA.
Benjamin DotyDivision of Research, American Psychiatric Association, Washington, DC, USA.
Sejal PatelDivision of Research, American Psychiatric Association, Washington, DC, USA.ORCID 0000-0002-8958-3219
Debbie GibsonDivision of Research, American Psychiatric Association, Washington, DC, USA.
Anna PaganoQuality and Science Department,American Society of Addiction Medicine, Rockville, MD, USA.
Laura ThompsonDivision of Research, American Psychiatric Association, Washington, DC, USA.
Amy B GoldsteinPrevention Research Branch,National Institute on Drug Abuse, Bethesda, MD, USA.
Frank VocciSocial Research Center, Friends Research Institute, Baltimore, MD, USA.ORCID 0000-0003-2143-0950
Robert P SchwartzSocial Research Center, Friends Research Institute, Baltimore, MD, USA.
American Psychiatric Association · USFriends Research Institute · USAmerican Society of Addiction Medicine · USJohns Hopkins University · USNational Institute on Drug Abuse · US

Funding

Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation TrialU01DA046910 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI SCHWARTZ, ROBERT P · 2018 to 2021
$4.8M
NIDA NIH HHS U01 DA046910
6 · The paper itself

Abstract

introductionThe need for innovative approaches to address the opioid epidemic in the United States is widely recognized. Many challenges exist to addressing this epidemic, including the obstacles outpatient substance use treatment practices face in implementing measurement-based care (MBC), quality measurement systems, and evidence-based treatments. Also, there are insufficient opportunities for clinicians in these settings to participate in research, resulting in diminished translation of research findings into community-based practice. To address these challenges, the Addiction Medicine Practice-Based Research Network (AMNet) was developed to facilitate the uptake of MBC in outpatient practices via implementation of patient-reported assessments and quality of care performance measures to improve patient outcomes. This network will offer clinicians in outpatient settings (not incuding opioid treatment programs [OTPs]) the opportunity to participate in future substance use disorder treatment research studies.

methodsA key step in the development of AMNet was the selection of substance use-specific assessment tools and quality of care performance measures for incorporation into the American Psychiatric Association's mental health patient registry, PsychPRO. A scoping review and multi-step consensus-based process were used to identify, review and select candidate assessment tools and quality of care performance measures for opioid use disorders (OUD) and substance use disorders (SUD).

resultsFollowing a consensus-based methodology, 12 standardized assessment tools and 3 quality of care performance measures for OUD and SUD were selected to help facilitate the implementation of MBC and quality improvement for AMNet participants. These tools were further categorized as core and optional.

conclusionBy offering a collection of carefully vetted assessment tools and quality measures through PsychPRO, AMNet will help participating clinicians with the systematic uptake of MBC and delivery of evidence-based treatment for patients with SUD. Also, AMNet will act as a centralized repository of data collected from patients and clinicians in non-OTP outpatient addiction medicine practices and serve as a platform for opioid treatment research.

Indexed as

addiction medicinemeasurement-based carepatient-reported outcome measuresquality improvementquality measures

Identifiers

PMID34211312
PMCPMC8240849
OpenAlexW3176405805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.